• Study reports abnormally high VTE and high bleed risk in critically ill COVID-19 patients and calls for more effective prevention strategies.
  • Clinicians at NHS hospitals are supporting the care of COVID-19 patients with the use of geko™ devices to reduce the risk of blood clots in the most at risk patients.
Learn more Contact us

OnPulse Technology

The revolutionary neuromuscular electrostimulation technology developed by Firstkind

Find out more

geko™ product

Hospital Applications Device

Find out more

geko™ product

Wound Therapy Applications Device

Find out more

Partner with us

What can the geko™ do for my patients?

News

The Dawning of a New Horizon for Venous Leg Ulcer Treatment

Blog

The geko™ device receives UK Conformity Assessed Mark

Social Media

Follow our social media channels to read our latest updates

Social Media